Stopping GLP-1 drugs can quickly erase cardiovascular benefits

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular ...

Type 1 diabetes associated with higher risk of dementia

Having type 1 diabetes is associated with a higher risk of developing dementia, according to a study published March 18, 2026, in Neurology. Type 2 diabetes is also associated with a higher risk of dementia compared with ...

PFAS exposure may weaken teens' bones

Early-life exposure to per- and polyfluoroalkyl substances (PFAS) may influence how children's bones develop during adolescence, according to new research published in the Journal of the Endocrine Society.

page 14 from 40